top of page
News, Events and Updates
Search
Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73
Jan 16, 2018
36th Annual J.P. Morgan Healthcare Conference in San Francisco on January 8th-11th
Jan 8, 2018
Anavex Life Sciences Reports Fiscal 2017 Financial Results & Provides Update On Therapeutic Programs
Dec 11, 2017
Anavex Life Sciences Reports New Data Demonstrate the Neuroprotective Features of Sigma-1 Receptor
Nov 21, 2017
Anavex Life Sciences to Present at the 5th Annual Mental Parity Addiction Equity Act Roundtable
Nov 8, 2017
5th Annual Mental Health Parity Equity Act Business Roundtable in Washington DC on 11/8/2017
Nov 6, 2017
Anavex Life Sciences presenting at Society for Neuroscience Nov. 11-15, 2017 in Washington DC
Nov 6, 2017
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer's Disease Treatment
Nov 3, 2017
10th Clinical Trials on Alzheimer's Disease CTAD November 1-4, 2017
Nov 3, 2017
Anavex Life Sciences at The Michael J. Fox Foundation's Parkinson's Disease Therapeutics Conference
Oct 29, 2017
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis at 7th ECTRIMS-ACTRIMS Meeting
Oct 26, 2017
23
24
25
26
27
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
